81. The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y12 Inhibitor in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
Dual antiplatelet therapy with aspirin and a P2Y12 inhibitor has been shown to reduce the risk of major adverse cardiovascular events (MACE) compared with aspirin alone after percutaneous coronary intervention (PCI) or acute coronary syndrome but with increased risk of bleeding. The safety of discontinuing aspirin in favor of P2Y12 inhibitor monotherapy remains disputed.
82. Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients.
作者: Peter Willeit.;Lena Tschiderer.;Elias Allara.;Kathrin Reuber.;Lisa Seekircher.;Lu Gao.;Ximing Liao.;Eva Lonn.;Hertzel C Gerstein.;Salim Yusuf.;Frank P Brouwers.;Folkert W Asselbergs.;Wiek van Gilst.;Sigmund A Anderssen.;Diederick E Grobbee.;John J P Kastelein.;Frank L J Visseren.;George Ntaios.;Apostolos I Hatzitolios.;Christos Savopoulos.;Pythia T Nieuwkerk.;Erik Stroes.;Matthew Walters.;Peter Higgins.;Jesse Dawson.;Paolo Gresele.;Giuseppe Guglielmini.;Rino Migliacci.;Marat Ezhov.;Maya Safarova.;Tatyana Balakhonova.;Eiichi Sato.;Mayuko Amaha.;Tsukasa Nakamura.;Kostas Kapellas.;Lisa M Jamieson.;Michael Skilton.;James A Blumenthal.;Alan Hinderliter.;Andrew Sherwood.;Patrick J Smith.;Michiel A van Agtmael.;Peter Reiss.;Marit G A van Vonderen.;Stefan Kiechl.;Gerhard Klingenschmid.;Matthias Sitzer.;Coen D A Stehouwer.;Heiko Uthoff.;Zhi-Yong Zou.;Ana R Cunha.;Mario F Neves.;Miles D Witham.;Hyun-Woong Park.;Moo-Sik Lee.;Jang-Ho Bae.;Enrique Bernal.;Kristian Wachtell.;Sverre E Kjeldsen.;Michael H Olsen.;David Preiss.;Naveed Sattar.;Edith Beishuizen.;Menno V Huisman.;Mark A Espeland.;Caroline Schmidt.;Stefan Agewall.;Ercan Ok.;Gülay Aşçi.;Eric de Groot.;Muriel P C Grooteman.;Peter J Blankestijn.;Michiel L Bots.;Michael J Sweeting.;Simon G Thompson.;Matthias W Lorenz.; .
来源: Circulation. 2020年142卷7期621-642页
To quantify the association between effects of interventions on carotid intima-media thickness (cIMT) progression and their effects on cardiovascular disease (CVD) risk.
83. Diagnosis of Infective Endocarditis by Subtype Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: A Contemporary Meta-Analysis.
作者: Tom Kai Ming Wang.;Alejandro Sánchez-Nadales.;Efehi Igbinomwanhia.;Paul Cremer.;Brian Griffin.;Bo Xu.
来源: Circ Cardiovasc Imaging. 2020年13卷6期e010600页
Background Infective endocarditis (IE) remains a difficult to diagnose condition associated with high mortality. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) has recently emerged as another IE imaging modality, although diagnostic accuracy varies across observational studies and types of IE. This meta-analysis assessed the diagnostic performance of 18F-FDG PET/CT for IE and its subtypes. Methods We searched Pubmed, Cochrane, and Embase from January 1980 to September 2019 for studies reporting both sensitivity and specificity of 18F-FDG PET/CT for IE. Meta-Disc 1.4 was used to pool data for all cases of IE and its subgroups of native valve IE, prosthetic valve IE, and cardiac implantable electronic devices IE. Results We screened 2566 records from the search, assessed 52 full-text articles, and included 26 studies totaling 1358 patients (509 IE cases). Pooled sensitivity and specificity (95% CI, inconsistency I-square statistic) were 0.74 (0.70-0.77, 71.5%) and 0.88 (0.86-0.91, 78.5%) for all cases of endocarditis. Corresponding parameters for native valve IE were sensitivity 0.31 (0.21-0.41, 29.4%) and specificity 0.98 (0.95-0.99, 34.4%); for prosthetic valve IE: sensitivity 0.86 (0.81-0.89, 60.0%) and specificity 0.84 (0.79-0.88, 75.2%); and for cardiac implantable electronic devices IE: sensitivity 0.72 (0.61-0.81, 76.2%) and specificity 0.83 (0.75-0.89, 83.6%). Pooled sensitivities and specificities were higher for the 17 studies since 2015 than the 9 studies published before 2015. Conclusions 18F-FDG PET/CT had high specificity for all IE subtypes; however, sensitivity was markedly lower for native valve IE than prosthetic valve IE and cardiac implantable electronic devices IE. It is, therefore, a useful adjunct modality for assessing endocarditis, especially in the challenging scenarios of prosthetic valve IE and cardiac implantable electronic devices IE, with improving performance over time, related to advances in 18F-FDG PET/CT techniques.
84. Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis.
作者: Pengwei Hu.;Kanika I Dharmayat.;Christophe A T Stevens.;Mansour T A Sharabiani.;Rebecca S Jones.;Gerald F Watts.;Jacques Genest.;Kausik K Ray.;Antonio J Vallejo-Vaz.
来源: Circulation. 2020年141卷22期1742-1759页
Contemporary studies suggest that familial hypercholesterolemia (FH) is more frequent than previously reported and increasingly recognized as affecting individuals of all ethnicities and across many regions of the world. Precise estimation of its global prevalence and prevalence across World Health Organization regions is needed to inform policies aiming at early detection and atherosclerotic cardiovascular disease (ASCVD) prevention. The present study aims to provide a comprehensive assessment and more reliable estimation of the prevalence of FH than hitherto possible in the general population (GP) and among patients with ASCVD.
85. Diagnosis-to-Ablation Time and Recurrence of Atrial Fibrillation Following Catheter Ablation: A Systematic Review and Meta-Analysis of Observational Studies.
作者: Derek S Chew.;Eric Black-Maier.;Zak Loring.;Peter A Noseworthy.;Douglas L Packer.;Derek V Exner.;Daniel B Mark.;Jonathan P Piccini.
来源: Circ Arrhythm Electrophysiol. 2020年13卷4期e008128页
The optimal timing of catheter ablation for atrial fibrillation (AF) in reference to the time of diagnosis is unknown. We sought to assess the impact of the duration between first diagnosis of AF and ablation, or diagnosis-to-ablation time (DAT), on AF recurrence following catheter ablation.
86. Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.
作者: Aya F Ozaki.;Austin S Choi.;Quan T Le.;Dennis T Ko.;Janet K Han.;Sandy S Park.;Cynthia A Jackevicius.
来源: Circ Cardiovasc Qual Outcomes. 2020年13卷3期e005969页
Stroke reduction with direct oral anticoagulants (DOACs) in atrial fibrillation (AF) is dependent on adherence and persistence in the real-world setting. Individual study estimates of DOAC adherence/persistence rates have been discordant. Our aims were to characterize real-world observational evidence for DOAC adherence/persistence and evaluate associated clinical outcomes in patients with AF.
87. Women's Participation in Cardiovascular Clinical Trials From 2010 to 2017.
作者: Xurui Jin.;Chanchal Chandramouli.;Brooke Allocco.;Enying Gong.;Carolyn S P Lam.;Lijing L Yan.
来源: Circulation. 2020年141卷7期540-548页
Cardiovascular disease is the leading cause of death among women worldwide, yet, women have historically been underrepresented in cardiovascular trials.
88. Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.
作者: Liza Chacko.;James P Howard.;Christopher Rajkumar.;Alexandra N Nowbar.;Christopher Kane.;Dina Mahdi.;Michael Foley.;Matthew Shun-Shin.;Graham Cole.;Sayan Sen.;Rasha Al-Lamee.;Darrel P Francis.;Yousif Ahmad.
来源: Circ Cardiovasc Qual Outcomes. 2020年13卷2期e006363页
In patients presenting with ST-segment-elevation myocardial infarction, percutaneous coronary intervention (PCI) reduces mortality when compared with fibrinolysis. In other forms of coronary artery disease (CAD), however, it has been controversial whether PCI reduces mortality. In this meta-analysis, we examine the benefits of PCI in (1) patients post-myocardial infarction (MI) who did not receive immediate revascularization; (2) patients who have undergone primary PCI for ST-segment-elevation myocardial infarction but have residual coronary lesions; (3) patients who have suffered a non-ST-segment-elevation acute coronary syndrome; and (4) patients with truly stable CAD with no recent infarct. This analysis includes data from the recently presented International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) and Complete versus Culprit-Only Revascularization Strategies to Treat Multivessel Disease after Early PCI for STEMI (COMPLETE) trials.
89. An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome.
作者: Arnon Adler.;Valeria Novelli.;Ahmad S Amin.;Emanuela Abiusi.;Melanie Care.;Eline A Nannenberg.;Harriet Feilotter.;Simona Amenta.;Daniela Mazza.;Hennie Bikker.;Amy C Sturm.;John Garcia.;Michael J Ackerman.;Raymond E Hershberger.;Marco V Perez.;Wojciech Zareba.;James S Ware.;Arthur A M Wilde.;Michael H Gollob.
来源: Circulation. 2020年141卷6期418-428页
Long QT syndrome (LQTS) is the first described and most common inherited arrhythmia. Over the last 25 years, multiple genes have been reported to cause this condition and are routinely tested in patients. Because of dramatic changes in our understanding of human genetic variation, reappraisal of reported genetic causes for LQTS is required.
90. Prognostic Significance of Left Ventricular Noncompaction: Systematic Review and Meta-Analysis of Observational Studies.
作者: Nay Aung.;Sara Doimo.;Fabrizio Ricci.;Mihir M Sanghvi.;Cesar Pedrosa.;Simon P Woodbridge.;Amer Al-Balah.;Filip Zemrak.;Mohammed Y Khanji.;Patricia B Munroe.;Huseyin Naci.;Steffen E Petersen.
来源: Circ Cardiovasc Imaging. 2020年13卷1期e009712页
Although left ventricular noncompaction (LVNC) has been associated with an increased risk of adverse cardiovascular events, the accurate incidence of cardiovascular morbidity and mortality is unknown. We, therefore, aimed to assess the incidence rate of LVNC-related cardiovascular events.
91. Major Adverse Cardiovascular Events Associated With Postoperative Atrial Fibrillation After Noncardiac Surgery: A Systematic Review and Meta-Analysis.
作者: Ahmed AlTurki.;Mariam Marafi.;Riccardo Proietti.;Daniela Cardinale.;Robert Blackwell.;Paul Dorian.;Amal Bessissow.;Lucy Vieira.;Isabelle Greiss.;Vidal Essebag.;Jeff S Healey.;Thao Huynh.
来源: Circ Arrhythm Electrophysiol. 2020年13卷1期e007437页
Postoperative atrial fibrillation (POAF) is a frequent occurrence after noncardiac surgery. It remains unclear whether POAF is associated with an increased risk of major adverse events. We aimed to elucidate the risk of stroke, myocardial infarction, and death associated with POAF following noncardiac surgery by a meta-analysis of randomized controlled studies and observational studies.
92. The Effect of Coconut Oil Consumption on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Clinical Trials.
Coconut oil is high in saturated fat and may, therefore, raise serum cholesterol concentrations, but beneficial effects on other cardiovascular risk factors have also been suggested. Therefore, we conducted a systematic review of the effect of coconut oil consumption on blood lipids and other cardiovascular risk factors compared with other cooking oils using data from clinical trials.
93. Individual Lesion-Level Meta-Analysis Comparing Various Doses of Intracoronary Bolus Injection of Adenosine With Intravenous Administration of Adenosine for Fractional Flow Reserve Assessment.
作者: Gilbert W M Wijntjens.;Ellen L van Uffelen.;Mauro Echavarría-Pinto.;Lorena Casadonte.;Valérie E Stegehuis.;Tadashi Murai.;Koen M J Marques.;Myeong-Ho Yoon.;Seung-Jea Tahk.;Gianni Casella.;Antonio M Leone.;Ramón López Palop.;Christian Schlundt.;Fernando Rivero.;Ricardo Petraco.;William F Fearon.;Nils P Johnson.;Allen Jeremias.;Bon-Kwon Koo.;Jan J Piek.;Tim P van de Hoef.
来源: Circ Cardiovasc Interv. 2020年13卷1期e007893页
Intravenous infusion of adenosine is considered standard practice for fractional flow reserve (FFR) assessment but is associated with adverse side-effects and is time-consuming. Intracoronary bolus injection of adenosine is better tolerated by patients, cheaper, and less time-consuming. However, current literature remains fragmented and modestly sized regarding the equivalence of intracoronary versus intravenous adenosine. We aim to investigate the relationship between intracoronary adenosine and intravenous adenosine to determine FFR.
94. Dietary Cholesterol and Cardiovascular Risk: A Science Advisory From the American Heart Association.
作者: Jo Ann S Carson.;Alice H Lichtenstein.;Cheryl A M Anderson.;Lawrence J Appel.;Penny M Kris-Etherton.;Katie A Meyer.;Kristina Petersen.;Tamar Polonsky.;Linda Van Horn.; .
来源: Circulation. 2020年141卷3期e39-e53页
The elimination of specific dietary cholesterol target recommendations in recent guidelines has raised questions about its role with respect to cardiovascular disease. This advisory was developed after a review of human studies on the relationship of dietary cholesterol with blood lipids, lipoproteins, and cardiovascular disease risk to address questions about the relevance of dietary cholesterol guidance for heart health. Evidence from observational studies conducted in several countries generally does not indicate a significant association with cardiovascular disease risk. Although meta-analyses of intervention studies differ in their findings, most associate intakes of cholesterol that exceed current average levels with elevated total or low-density lipoprotein cholesterol concentrations. Dietary guidance should focus on healthy dietary patterns (eg, Mediterranean-style and DASH [Dietary Approaches to Stop Hypertension]-style diets) that are inherently relatively low in cholesterol with typical levels similar to the current US intake. These patterns emphasize fruits, vegetables, whole grains, low-fat or fat-free dairy products, lean protein sources, nuts, seeds, and liquid vegetable oils. A recommendation that gives a specific dietary cholesterol target within the context of food-based advice is challenging for clinicians and consumers to implement; hence, guidance focused on dietary patterns is more likely to improve diet quality and to promote cardiovascular health.
95. Systematic Evaluation of the Robustness of the Evidence Supporting Current Guidelines on Myocardial Revascularization Using the Fragility Index.
作者: Mario Gaudino.;Irbaz Hameed.;Giuseppe Biondi-Zoccai.;Derrick Y Tam.;Stephen Gerry.;Mohamed Rahouma.;Faiza M Khan.;Dominick J Angiolillo.;Umberto Benedetto.;David P Taggart.;Leonard N Girardi.;Filippo Crea.;Marc Ruel.;Stephen E Fremes.
来源: Circ Cardiovasc Qual Outcomes. 2019年12卷12期e006017页
RCTs (randomized controlled trials) are the preferred source of evidence to support professional societies' guidelines. The fragility index (FI), defined as the minimum number of patients whose status would need to switch from nonevent to event to render a statistically significant result nonsignificant, quantitatively estimates the robustness of RCT results. We evaluate RCTs supporting current guidelines on myocardial revascularization using the FI and FI minus number of patients lost to follow-up.
96. Renewal Theory as a Universal Quantitative Framework to Characterize Phase Singularity Regeneration in Mammalian Cardiac Fibrillation.
作者: Dhani Dharmaprani.;Madeline Schopp.;Pawel Kuklik.;Darius Chapman.;Anandaroop Lahiri.;Lukah Dykes.;Feng Xiong.;Martin Aguilar.;Benjamin Strauss.;Lewis Mitchell.;Kenneth Pope.;Christian Meyer.;Stephan Willems.;Fadi G Akar.;Stanley Nattel.;Andrew D McGavigan.;Anand N Ganesan.
来源: Circ Arrhythm Electrophysiol. 2019年12卷12期e007569页
Despite a century of research, no clear quantitative framework exists to model the fundamental processes responsible for the continuous formation and destruction of phase singularities (PS) in cardiac fibrillation. We hypothesized PS formation/destruction in fibrillation could be modeled as self-regenerating Poisson renewal processes, producing exponential distributions of interevent times governed by constant rate parameters defined by the prevailing properties of each system.
97. Outcomes With Deferred Versus Performed Revascularization of Coronary Lesions With Gray-Zone Fractional Flow Reserve Values.
作者: Michael Megaly.;Charl Khalil.;Marwan Saad.;Iosif Xenogiannis.;Mohamed Omer.;Mahesh Anantha Narayanan.;Ashish Pershad.;Santiago Garcia.;Arnold H Seto.;M Nicholas Burke.;Emmanouil S Brilakis.
来源: Circ Cardiovasc Interv. 2019年12卷12期e008315页
Management of coronary lesions with fractional flow reserve values in the gray zone (0.75-0.80) remains controversial due to conflicting data on the performance versus deferral of revascularization.
98. Peri-Infarct Quantification by Cardiac Magnetic Resonance to Predict Outcomes in Ischemic Cardiomyopathy: Prognostic Systematic Review and Meta-Analysis.
作者: Hourmazd Haghbayan.;Nick Lougheed.;Djeven P Deva.;Kelvin K W Chan.;João A C Lima.;Andrew T Yan.
来源: Circ Cardiovasc Imaging. 2019年12卷11期e009156页
In ischemic cardiomyopathy, cardiac magnetic resonance assessment of the peri-infarct zone, a potential substrate for arrhythmogenesis, may serve as a novel prognosticator and guide the optimal use of implantable cardioverter-defibrillators. We undertook a systematic review and meta-analysis assessing the prognostic value of the peri-infarct zone on late gadolinium enhancement cardiac magnetic resonance in ischemic cardiomyopathy.
99. Optimal Strategy and Timing of Left Ventricular Venting During Veno-Arterial Extracorporeal Life Support for Adults in Cardiogenic Shock: A Systematic Review and Meta-Analysis.
作者: Abdulrahman A Al-Fares.;Varinder K Randhawa.;Marina Englesakis.;Michael A McDonald.;A Dave Nagpal.;Jerry D Estep.;Edward G Soltesz.;Eddy Fan.
来源: Circ Heart Fail. 2019年12卷11期e006486页
Veno-arterial extracorporeal life support (VA-ECLS) is widely used to treat refractory cardiogenic shock. However, increased left ventricular (LV) afterload in VA-ECLS can worsen pulmonary congestion and compromise myocardial recovery. Our objectives were to explore the efficacy, safety, and optimal timing of adjunctive LV venting strategies.
100. Antiarrhythmic Drugs or Catheter Ablation in the Management of Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter-Defibrillators: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
作者: Babikir Kheiri.;Mahmoud Barbarawi.;Yazan Zayed.;Michael Hicks.;Mohammed Osman.;Laith Rashdan.;Htay Htay Kyi.;Ghassan Bachuwa.;Mustafa Hassan.;Eric C Stecker.;Babak Nazer.;Deepak L Bhatt.
来源: Circ Arrhythm Electrophysiol. 2019年12卷11期e007600页
In patients with an implantable cardioverter-defibrillator (ICD), shocks are associated with increased morbidity and mortality. Therefore, we conducted this study to evaluate the efficacy and safety of antiarrhythmic drugs and catheter ablation (CA) in the treatment of ventricular tachyarrhythmias (VT) in patients with an ICD.
|